NEW YORK (GenomeWeb) – Using a Quidel Sofia influenza immunoassay as an initial screening tool saved Tufts Medical Center approximately $36,000 during the 2014 winter flu season, researchers at the center have reported.

In a retrospective analysis of a respiratory illness testing algorithm using the Quidel assay prior to syndromic testing with the BioFire FilmArray respiratory panel, clinicians and laboratorians at Tufts said the $36,000 was saved in comparison to a summer period in which the 20-target FilmArray panel test was used alone as the first-line assay.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.